Panion & Bf Biotech Inc. (TPE:1760)
Taiwan · Delayed Price · Currency is TWD 56.00
-0.40 (-0.71%)
Sep 8, 2026, 1:30 PM CST
Panion & Bf Biotech Market Cap
Panion & Bf Biotech has a market cap or net worth of 4.84 billion as of September 8, 2026. Its market cap has decreased by -22.95% in one year.
Market Cap
4.84B
Enterprise Value
5.00B
Revenue
2.11B
Ranking
n/a
PE Ratio
22.56
Stock Price
56.00
ChartMarket Cap Chart
Since September 30, 2004, Panion & Bf Biotech's market cap has increased from 534.45M to 4.84B, an increase of 804.79%. That is a compound annual growth rate of 10.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 4.84B | -10.48% |
| Dec 31, 2025 | 5.40B | -23.26% |
| Dec 31, 2024 | 7.04B | -26.70% |
| Dec 29, 2023 | 9.60B | -37.43% |
| Dec 30, 2022 | 15.35B | 138.03% |
| Dec 30, 2021 | 6.45B | -1.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SCI Pharmtech | 6.43B |
| Alar Pharmaceuticals | 6.28B |
| Orient Pharma | 6.11B |
| Formosa Laboratories | 5.48B |
| LIWANLI Innovation | 4.66B |
| Yoda Pharmaceuticals | 4.61B |
| Orient EuroPharma | 3.99B |
| Easywell Biomedicals | 3.73B |